According to the Market Statsville Group (MSG), the Global Viral Gastroenteritis Drugs Market size is expected to grow at a CAGR of 7.2% from 2023 to 2033.
Viral gastroenteritis is the stomach flu or stomach bug, a highly contagious infection of the gastrointestinal tract. It is caused by various viruses, such as norovirus, rotavirus, and adenovirus, and is characterized by symptoms like diarrhea, vomiting, abdominal pain, and sometimes fever. Viral gastroenteritis drug or medication maintains hydration in the body. It helps in maintaining the fluid which had been lost due to vomiting and diarrhea. These drugs block certain receptors in the brain responsible for triggering the vomiting reflex.
The surging prevalence of viral gastroenteritis, affecting people of all ages and demographics is the major driving factor of the market. The new viral strains, like norovirus variants, have raised concerns for more severe outbreaks which increases the demand for the development of novel drugs or treatments, further boosting demand in the market. The growing international travel and tourism as well as cruise travelling enhances the chances of viral gastroenteritis, thereby fostering the market’s growth. Also, the rising aging population and the increasing number of pipeline medications and clinical research create a lucrative growth opportunity for the market.
With an increase in viral gastroenteritis cases worldwide, there is a growing demand for antiviral medications and treatments. Research and development advancements, such as the development of novel drug candidates and vaccines, offer optimistic growth opportunities for the market. In addition, heightened awareness of hygiene and prevention measures is anticipated to increase demand for prophylactic treatments. As the market continues to address the healthcare burden of viral gastroenteritis, it possesses substantial potential for expansion and innovation in pharmaceuticals and healthcare solutions.
Based on application, the market is divided into hospitals, clinics, and others. The hospitals applications contributes majorly to the market growth, accounted for the largest market share in 2023. Hospitals encounter severe cases of viral gastroenteritis, of all age populations like young children, the elderly, and individuals with unstable immune systems. These cases require hospitalization and intensive care for subtle complications such as dehydration, electrolyte imbalances, and organ dysfunction. Also, hospitals see the high patient pool and have a larger number of healthcare professionals which subsequently augments the market’s growth.
Based on the geographical standpoint, the global viral gastroenteritis drugs market has been segmented across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America accounted for the largest market share in 2023. The growing incidence of viral gastroenteritis in the region is the major driver of the market. The region has a well-established healthcare infrastructure and diagnosis treatment that boosts the market’s growth. Further, increasing public awareness about gastrointestinal infections, their potential severity, and the importance of appropriate treatment is another factor that contributes to the market’s growth over the forecast period.
Rising healthcare expenditures and a sizable population contribute to market expansion in Asia-Pacific. Latin America and the Middle East are emerging markets where gastroenteritis cases are rising. Due to its limited healthcare resources, Africa confronts obstacles to market penetration. Variations in the viral gastroenteritis drugs market in various regions of the globe are caused by regional differences in healthcare access, economic factors, and disease prevalence.
Intense research and development efforts stimulate innovation, resulting in the release of new antiviral medications. Important factors in market competition include pricing strategies, regulatory approvals, and distribution networks. In addition, partnerships, mergers, and acquisitions are common strategies utilized to strengthen public positions. With a growing emphasis on developing effective and safe treatments for viral gastroenteritis, it is anticipated that competition will remain fierce in the rapidly evolving pharmaceutical industry. The Major key players in the global viral gastroenteritis drugs market are:
This market research study categorizes the viral gastroenteritis drugs market-based on type, and application area at the regional and global levels.
Frequently Asked Questions
The global viral gastroenteritis drugs market has a potential to grow at a CAGR of 11.4% from 2023 to 2033.
The main players operating in the market are Pfizer, AbbVie, Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc, C.H.Boehringer Sohn AG & Co.KG, Daiichi Sankyo Company Limited Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, among others.
The increasing awareness of the importance of appropriate treatment and the potential for innovative drug development present growth opportunities while the misuse of antibiotics and the emergence of antibiotic-resistant strains due to misdiagnosis of viral gastroenteritis pose significant risks to public health.
Key trends, innovations, and technological advancements in the viral gastroenteritis drugs market include the development of novel antiviral therapies, the utilization of advanced diagnostic tools for precise virus identification, and the exploration of vaccine candidates to prevent viral gastroenteritis infections.
Consumers in the viral gastroenteritis drugs market typically seek easily accessible over-the-counter remedies for symptom relief, prioritize medications with a proven track record of effectiveness, and consult healthcare professionals for severe cases or to confirm the need for prescription antiviral drugs.
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Metagenomics Sequencing Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Medical Cannabis Oil Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Novel Vaccine Delivery System Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Lysosomal Storage Disease Treatment Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Single-Use Bioprocessing Market 2022: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024